Alzheimer's Disease News and Research

RSS

Alzheimer's disease (AD) is an irreversible, progressive brain disease that slowly destroys memory and thinking skills and, eventually, the ability to carry out the simplest tasks of daily living. In most people with AD, symptoms first appear after age 60. AD is the most common cause of dementia among older people, but it is not a normal part of aging. Dementia refers to a decline in cognitive function that interferes with daily life and activities. AD starts in a region of the brain that affects recent memory, then gradually spreads to other parts of the brain. Although treatment can slow the progression of AD and help manage its symptoms in some people, currently there is no cure for this devastating disease.

Living Cell Technologies announces results for treating Huntington's disease

Living Cell Technologies announced pre-clinical results today showing its brain protection product, NeurotrophinCell (NtCell) produces a marked reduction in the size of brain lesions in a Huntington's disease (HD) model.

2 Aug 2005

People have signs of Alzheimer's years before diagnosis

Psychologists say that after examining dozens of Alzheimer's studies, they now have a clear picture of the cognitive problems which will develop in people with the degenerative brain disease.

1 Aug 2005

People can show early warning signs of Alzheimer's disease years before they are officially diagnosed

By combing through dozens of Alzheimer's disease (AD) studies, psychologists have gained a clear picture of cognitive problems in people who will develop the degenerative brain disease.

1 Aug 2005

New research says binge before bedtime and shed weight!

According to new research, dieters who binge before bedtime could hold the key to weight loss.

29 Jul 2005

Anti-inflammatory function of Alzheimer's disease drugs revealed

The mechanism in anti-Alzheimer's disease drugs that inhibits the production of a destructive, inflammation-causing protein in the brain has been revealed by researchers at the Hebrew university of Jerusalem.

28 Jul 2005

New breakthrough on the origins of Alzheimer's disease

Scientists from the Flanders Interuniversity Institute for Biotechnology (VIB) associated with the University of Antwerp have achieved a new breakthrough in their research on the origins of Alzheimer's disease.

27 Jul 2005

Adding spectroscopy to breast MR examinations may improve the efficiency and quality of patient care

Measuring the biochemical changes in breast tumors with magnetic resonance (MR) spectroscopy enables radiologists to more accurately distinguish benign tumors from cancerous ones, according to a study appearing in the August issue of the journal Radiology.

26 Jul 2005

Plaques in the brain more likely to be expressed as dementia in women than in men

Researchers from the Rush Alzheimer's Disease Center found that plaques and tangles in the brain, the changes seen in people with Alzheimer's disease (AD), are more likely to be expressed as dementia in women than in men.

25 Jul 2005

U.S. scientists find 3 molecules that could help fight Alzheimer's

A team of scientists at the Neuroscience Research Institute at the University of California, Santa Barbara, say they have identified three molecules that appear to stop a key culprit behind Alzheimer's disease.

25 Jul 2005

New clues for the understanding of dementia

Researchers at the Medical Research Council MRC Prion Unit and the Department of Neurodegenerative Disease at the Institute of Neurology, University College London - in collaboration with groups from Copenhagen, Aarhus, Lund and Cambridge - have identified a gene that, when mutated, causes an early onset dementia.

24 Jul 2005

UK medical watchdog wants more proof on value of Alzheimer's drugs

In the UK the country's watchdog for cost-effectiveness in medical treatments, the National Institute for Health and Clinical Excellence (NICE), has asked drug makers for more evidence about the benefits of their Alzheimer's medicines.

21 Jul 2005

Definitive proof that Ab42 is the culprit molecule that underlies the pathology of Alzheimer's disease

One puzzle in Alzheimer's disease (AD) research is why mice engineered to have the abnormal protein underlying the disease in humans show little pathology of the disease. Specifically, such mice are genetically altered to overproduce mutant human amyloid precursor protein (APP).

21 Jul 2005

New research suggests that accumulation of amyloid-beta peptides in cerebral blood vessels causes vascular damage in Alzheimer's disease

New research suggests that accumulation of amyloid-â peptides in cerebral blood vessels, as opposed to the brain itself, may be a more important pathological mediator of Alzheimer's disease. Two independent yet related articles describe such findings in the August issue of The American Journal of Pathology.

21 Jul 2005

Eighty-three percent of Medicare beneficiaries have at least one chronic condition

Eighty-three percent of Medicare beneficiaries have at least one chronic condition, such as congestive heart failure, Alzheimer's disease or diabetes. Two-thirds of Medicare spending is incurred by the 9.5 million beneficiaries with five or more chronic conditions. These percentages suggest that the Medicare program needs to address chronic conditions rather than the acute, episodic illnesses that have been the focus of the Medicare program since it began in 1966.

20 Jul 2005

Research examines the effect of visual impairment on Alzheimer's disease patients in nursing homes

One in three nursing home residents who have Alzheimer’s disease are not getting their vision corrected so they can see clearly, according to new Saint Louis University research in the July issue of the Journal of the American Medical Directors Association.

20 Jul 2005

Researchers have identified a protein that is crucially involved in how our memories are stored and processed

University of Queensland researchers have identified a protein that is crucially involved in how our memories are stored and processed, paving the way for new strategies to treat conditions certain mental disorders.

18 Jul 2005

Lipid helps cell wall protein fold into proper shape

A protein that provides a vital passage through a bacterium's outer cell wall will misfold and malfunction if that wall is built of the 'wrong' material, scientists at The University of Texas Medical School at Houston report in a finding that has long-term implications for understanding diseases caused by misfolded proteins such as cystic fibrosis, Alzheimer's disease, and mad cow disease.

17 Jul 2005

Having asthma, hay fever or another allergic condition may reduce the risk of developing Glioblastoma multiforme

Glioblastoma multiforme (GBM) affects three out of 100,000 people, a rate that quadruples to 13 out 100,000 among people who are 65 and older. The average five-year survival rate from the time of diagnosis for GBM is only 3.3 percent, and is lower for people 65 and older.

15 Jul 2005

Statins not effective in reducing dementia risk

According to a recently published study, the use of statins and other lipid-lowering agents by older adults is not associated with a reduced risk of Alzheimer's disease or other types of dementia.

12 Jul 2005

New insights into brain cell metabolism from PET and MRI scans

By discovering a crucial piece of submicroscopic information about how the brain converts fuel into energy for neurons, Cornell University biophysicists have gleaned new insights into brain cell metabolism that will allow neurologists to better interpret data from such diagnostic tests as positron emission tomography (PET) scans and a specialized magnetic resonance imaging (MRI) test.

12 Jul 2005

Alzheimer's Disease News and Research

Further Reading

Living Cell Technologies announces results for treating Huntington's disease

People have signs of Alzheimer's years before diagnosis

People can show early warning signs of Alzheimer's disease years before they are officially diagnosed

New research says binge before bedtime and shed weight!

Anti-inflammatory function of Alzheimer's disease drugs revealed

New breakthrough on the origins of Alzheimer's disease

Adding spectroscopy to breast MR examinations may improve the efficiency and quality of patient care

Plaques in the brain more likely to be expressed as dementia in women than in men

U.S. scientists find 3 molecules that could help fight Alzheimer's

New clues for the understanding of dementia

UK medical watchdog wants more proof on value of Alzheimer's drugs

Definitive proof that Ab42 is the culprit molecule that underlies the pathology of Alzheimer's disease

New research suggests that accumulation of amyloid-beta peptides in cerebral blood vessels causes vascular damage in Alzheimer's disease

Eighty-three percent of Medicare beneficiaries have at least one chronic condition

Research examines the effect of visual impairment on Alzheimer's disease patients in nursing homes

Researchers have identified a protein that is crucially involved in how our memories are stored and processed

Lipid helps cell wall protein fold into proper shape

Having asthma, hay fever or another allergic condition may reduce the risk of developing Glioblastoma multiforme

Statins not effective in reducing dementia risk

New insights into brain cell metabolism from PET and MRI scans

eBook: Advancing neurodegenerative research with iPSC-derived microglia models eBook

How ELRIG Is Helping Mid-Career Scientists Navigate Leadership, Career Change and Redundancy

The role of UV-Vis in biopharma QC

Applications Engineer

Latest News